Complement in CPD-stored blood. 1982

J A Schifferli, and H Boralessa, and H L Howarth, and J G Whitwam, and A J Rees

We studied complement functions, breakdown of C3 and aggregation of immunoglobulins in whole blood stored in citrate phosphate dextrose at 4 degrees C for up to 3 weeks from 10 normal blood donors. No significant changes in total haemolytic complement (CH50) and alternative pathway haemolytic complement activity were detected. However, the complement-mediated capacity of the sera to solubilise a pre-formed immune precipitate decreased significantly at 2 and 3 weeks (p less than 0.02 at 2 weeks, p less than 0.003 at 3 weeks). No C3 conversion could be detected by immunoelectrophoresis but alteration in C3 was attested by a significant increase in breakdown products of C3 by 1 week (p less than 0.002) and all were above the normal range after 3 weeks (p less than 0.0001). No aggregation of immunoglobulins could be detected using two immune complex assays.

UI MeSH Term Description Entries
D001793 Blood Preservation The process by which blood or its components are kept viable outside of the organism from which they are derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Blood Preservations,Preservation, Blood,Preservations, Blood
D002951 Citrates Derivatives of CITRIC ACID.
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003170 Complement Pathway, Alternative Complement activation initiated by the interaction of microbial ANTIGENS with COMPLEMENT C3B. When COMPLEMENT FACTOR B binds to the membrane-bound C3b, COMPLEMENT FACTOR D cleaves it to form alternative C3 CONVERTASE (C3BBB) which, stabilized by COMPLEMENT FACTOR P, is able to cleave multiple COMPLEMENT C3 to form alternative C5 CONVERTASE (C3BBB3B) leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX. Alternative Complement Pathway,Properdin Pathway,Alternative Complement Activation Pathway,Complement Activation Pathway, Alternative
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune

Related Publications

J A Schifferli, and H Boralessa, and H L Howarth, and J G Whitwam, and A J Rees
January 1975, Transfusion,
J A Schifferli, and H Boralessa, and H L Howarth, and J G Whitwam, and A J Rees
January 1969, Transfusion,
J A Schifferli, and H Boralessa, and H L Howarth, and J G Whitwam, and A J Rees
August 1980, Anaesthesia and intensive care,
J A Schifferli, and H Boralessa, and H L Howarth, and J G Whitwam, and A J Rees
January 1974, Transfusion,
J A Schifferli, and H Boralessa, and H L Howarth, and J G Whitwam, and A J Rees
January 1973, Biology of the neonate,
J A Schifferli, and H Boralessa, and H L Howarth, and J G Whitwam, and A J Rees
July 1975, The Journal of thoracic and cardiovascular surgery,
J A Schifferli, and H Boralessa, and H L Howarth, and J G Whitwam, and A J Rees
January 1968, Transfusion,
J A Schifferli, and H Boralessa, and H L Howarth, and J G Whitwam, and A J Rees
January 1980, Folia haematologica (Leipzig, Germany : 1928),
J A Schifferli, and H Boralessa, and H L Howarth, and J G Whitwam, and A J Rees
January 1979, Transfusion,
J A Schifferli, and H Boralessa, and H L Howarth, and J G Whitwam, and A J Rees
August 2001, Transfusion,
Copied contents to your clipboard!